These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8271524)

  • 1. Effects of semotiadil fumarate, a novel calcium antagonist, on blood pressure and heart rate in conscious spontaneously hypertensive rats.
    Kanda A; Hashimoto H
    Jpn J Pharmacol; 1993 Sep; 63(1):121-4. PubMed ID: 8271524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of a novel calcium antagonist, semotiadil fumarate (SD-3211), alone and in combination with enalapril or trichlormethiazide in spontaneously hypertensive rats.
    Ichikawa M; Wanaka M; Ohtsuji T; Akashi S; Machidera Y; Manno K; Nakamuta H; Koida M
    Biol Pharm Bull; 1994 Nov; 17(11):1513-5. PubMed ID: 7703975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats.
    Petty MA; Mir AK
    Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats.
    Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of semotiadil, a novel Ca2+ channel antagonist, on the electrical activity of Langendorff-perfused guinea pig hearts in comparison with diltiazem, amlodipine and nifedipine.
    Stark G; Kasper K; Stark U; Miyawaki N; Decrinis M; Tritthart HA
    Eur J Pharmacol; 1995 Nov; 286(1):71-8. PubMed ID: 8566153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.
    Mori T; Ishigai Y; Fukuzawa A; Chiba K; Shibano T
    Br J Pharmacol; 1995 Sep; 116(1):1668-72. PubMed ID: 8564235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
    Ikeno A; Nose I; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1993 May; 21(5):815-21. PubMed ID: 7685454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
    Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Murata K
    Eur J Pharmacol; 1996 Jan; 295(2-3):229-34. PubMed ID: 8720589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
    Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel benzothiazine Ca2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca2+ currents.
    Koidl B; Miyawaki N; Tritthart HA
    Eur J Pharmacol; 1997 Mar; 322(2-3):243-7. PubMed ID: 9098694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet activity of semotiadil fumarate.
    Wolfram RM; Kritz H; Oguogho A; Sinzinger H
    Thromb Res; 2002 May; 106(4-5):187-90. PubMed ID: 12297124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
    Knorr A
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):141-50. PubMed ID: 7165419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects.
    Zwadlo C; Borlak J
    Vascul Pharmacol; 2016 Dec; 87():121-128. PubMed ID: 27613148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.